Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,548.00
(
1.89%
)
Dow Jones
49,247.66
(
-0.13%
)
Brent Oil
100.66
(
0.00%
)
Bitcoin
77,625.02
(
0.20%
)
News Focus
News Focus
Post# of 822788
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Investor082

Send PM Follow Ignore
Followers 4
Posts 5112
Boards Moderated 1
Alias Born 03/21/2024

Investor082

Re: XMaster2023 post# 732683

Sunday, 11/17/2024 10:23:10 PM

Sunday, November 17, 2024 10:23:10 PM

Post# of 822788
Don’t cry manipulation when there is no non dilutive funds in connection with the combo trial. LP will be forced to dilute. So it’s all on LP.

They lied to shareholders in 2017 and this is going to run a similar fate. Let’s check again in Q1 2025.

JAMA has been out for over 2 years. Yet Specials revenue is abysmal. It won’t change much with the UK approval either without NICE reimbursement support. So the bleeding will continue for a couple of years! ;)
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News